# Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

> **NCT01135563** · PHASE1 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 14 (actual)

## Conditions studied

- Solid Tumors
- Central Nervous System Tumors

## Interventions

- **DRUG:** Vinblastine and Sirolimus

## Key facts

- **NCT ID:** NCT01135563
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135563, "Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01135563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*